Clinical subgroup of autoimmune hepatitis type 1 sustaining remission without additional drugs

Hepato-Gastroenterology

Volumn 45, Issue 23, 1998, Pages 1667-1672

  Ohana, Masaya ^a   Hajiro, Kiyoshi ^a   Okazaki, Kazuichi ^a   Haga, Hironori ^b   Kobashi, Yoichiro ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NONE

Author keywords

Immunosuppressants; Prednisolone; Serum gammaglobulin level; Steroid therapy

Indexed keywords

IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LIVER BIOPSY; MALE; PRIORITY JOURNAL; RECURRENCE RISK; REMISSION; SURVIVAL TIME;

ANTI-INFLAMMATORY AGENTS; FEMALE; GAMMA-GLOBULINS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PREDNISOLONE; RECURRENCE; REMISSION INDUCTION;

EID: 0031735234     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Manns MP: Autoimmune hepatitis. In: Haubrich WS, Schaffner F, Beak JE, eds. Bockus Gastroenterology. 5th ed. Philadelphia: Saunders, 1994; 2151-2157.
2. Stellen AJ, Heating JJ, Johnson PJ, McFarlane IG, Williams R: Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal. Hepatology 1988; 8: 781-784.
3. Johnson PJ, McFarlane IG, Williams R: Azathioprine for long-term maintenance of remmission in autoimmune hepatitis. N Engl J Med 1995; 333: 958-963.
4. Hyams JS, Ballow M, Leichtner AM: Cyclosporine treatment of autoimmune chronic active hepatitis. Gastroenterology 1987; 93: 890-893.
5. Pratt DS, Flavin DP, Kaplan MM: The successful treatment of autoimmune hepatitis with 6-mercaptopurine after failure with azathioprine. Gastroenterology 1996; 110: 271-274.
6. Hegarty JE, Nouri Aria KT, Portmann B, Eddleston ALWF, Williams R: Relapse following treatment withdrawal in patients with autoimmune chronic hepatitis. Hepatology 1983; 3: 685-689.
7. Czaja AJ, Ludwig J, Bagenstoss AH, Wolf A: Corticosteroid-treated chronic active hepatitis in remission: Uncertain prognosis of chronic persistent hepatitis. N Engl J Med 1981; 304: 5-9.
8. Johnson PJ, McFarlane IG: Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18: 998-1005.
9. Bianchi FB, Cassani F, Lenzi M, Ballardini G, Muratori L, Giostra F, Zauli D: Impact of international autoimmune hepatitis group scoring system in definition of autoimmune hepatitis. An Italian experience. Dig Dis Sci 1996; 41: 166-171.
10. Czaja AJ, Carpenter HA: Validation of scoring system for diagnosis of autoimmune hepatitis. Dig Dis Sci 1996; 41: 305-314.
11. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1997; 9: 1513-1520.
12. Schapiro GD, Friedman LS: Autoimmune hepatitis and/or hepatitis C: How to decide. Hepatology 1996; 23: 647-649.
13. Osada K, Sameshima Y, Fujii H, Shimizu M, Watanabe J, Nishioka K: Effect of donor blood screening for anti-HCV antibody by the second-generation passive hemagglutination test on the incidence of post-transfusion hepatitis. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994; 562-564.
14. Ohana M, Hajiro K, Takakuwa H, Okazaki, K: Clinical features of serologically non-B non-C chronic liver disease. Hepato-Gastroenterol 1997; 44: 215-220
15. Seki T, Ota M, Furuta S, Fukushima H, Kondo T, Hino K, Mizuki N, et al. HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients. Gastroenterology 1992; 103: 1041-7.
16. Czaja AJ: Autoimmune hepatitis. Evolving concepts and treatment strategies. Dig Dis Sci 1995; 40: 435-56.
17. Kirk AP, Jain S, Pocock S, Thomas HC, Sherlock S: Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. Gut 1980; 21: 78-83.
18. Sanchez UL, Czaja AJ, van HB, Krom RA, Wiesner RH: Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis. Hepatology 1992; 15: 215-21.
19. Lashner BA, Jonas RB, Tang H-S, Evans AA, Ozeran SE, Baker AL: Chronic hepatitis: Disease factors at diagnosis predictive of mortality. Am J Med 1988; 85: 609-614.
20. Roberts SK, Therneau TM, Czaja AJ: Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology 1996; 110: 848-857.
21. Krawitt EL: Autoimmune hepatitis. N Engl J Med 1996; 334: 897-903.
22. Golbus MS: Teratology for the obstetrician: Current status. Obstet Gynecol 1980; 55: 269-277.
23. Wang KK, Czaja AJ, Beaver SJ, Go VL: Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis. Hepatology 1989; 10: 39-43.
24. Donaldson PT, Doherty DG, Hayllar KM, McFarlane IG, Johnson PJ, Williams R: Susceptibility to autoimmune chronic active hepatitis: Human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors. Hepatology 1991; 13: 701-706.
25. Meyer zum Boschenfelde KH, Lohse AW: Autoimmune hepatitis (Editorial). N Engl J Med 1995; 333: 1004-1005.
26. Czaja AJ, Pheifer KD, Decker RH, Vallari AS: Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis. Dig Dis Sci 1996; 41: 1733-1740.
27. Czaja AJ: Low-dose corticosteroid therapy after multiple relapses of severe HBs Ag-negative chronic active hepatitis. Hepatology 1990; 11: 1044-1049.